CA2668645A1 - Method of treating asthma, allergic rhinitis, and skin disorders - Google Patents

Method of treating asthma, allergic rhinitis, and skin disorders Download PDF

Info

Publication number
CA2668645A1
CA2668645A1 CA002668645A CA2668645A CA2668645A1 CA 2668645 A1 CA2668645 A1 CA 2668645A1 CA 002668645 A CA002668645 A CA 002668645A CA 2668645 A CA2668645 A CA 2668645A CA 2668645 A1 CA2668645 A1 CA 2668645A1
Authority
CA
Canada
Prior art keywords
formula
compound
alkyl
cycloalkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002668645A
Other languages
English (en)
French (fr)
Inventor
Peter G. Klimko
Clay Beauregard
Bryon S. Severns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Research LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2668645A1 publication Critical patent/CA2668645A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
CA002668645A 2006-11-07 2007-11-06 Method of treating asthma, allergic rhinitis, and skin disorders Abandoned CA2668645A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85733906P 2006-11-07 2006-11-07
US60/857,339 2006-11-07
PCT/US2007/083695 WO2008058098A2 (en) 2006-11-07 2007-11-06 Method of treating asthma, allergic rhinitis, and skin disorders

Publications (1)

Publication Number Publication Date
CA2668645A1 true CA2668645A1 (en) 2008-05-15

Family

ID=39276163

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002668645A Abandoned CA2668645A1 (en) 2006-11-07 2007-11-06 Method of treating asthma, allergic rhinitis, and skin disorders

Country Status (12)

Country Link
US (2) US20080108695A1 (enExample)
EP (1) EP2079459A2 (enExample)
JP (1) JP2010509240A (enExample)
KR (1) KR20090086573A (enExample)
CN (1) CN101534806A (enExample)
AU (1) AU2007316482A1 (enExample)
BR (1) BRPI0718540A2 (enExample)
CA (1) CA2668645A1 (enExample)
MX (1) MX2009004962A (enExample)
TW (1) TW200829232A (enExample)
WO (1) WO2008058098A2 (enExample)
ZA (1) ZA200902909B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687539B1 (en) * 2005-11-07 2010-03-30 Alcon Research, Ltd. Method of treating ocular allergy
WO2011096941A1 (en) * 2010-02-08 2011-08-11 Alcon Research, Ltd. Method of treating ocular allergy
EP2538934A1 (en) * 2010-02-25 2013-01-02 Alcon Research, Ltd. Method of accelerating corneal wound healing
CN110840878B (zh) * 2019-11-05 2020-06-26 牡丹江医学院 一种用于治疗银屑病的化合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286730A (en) * 1991-09-17 1994-02-15 American Home Products Corporation Method of treating immunoinflammatory disease
FR2701477B1 (fr) * 1993-02-16 1995-03-31 Adir Nouveaux composés (cyclohexyl)alcéniques, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
US6887901B1 (en) * 1993-06-15 2005-05-03 Brigham & Women's Hospital, Inc. Lipoxin compounds and their use in treating cell proliferative disorders
EP0703897B1 (en) * 1993-06-15 2008-08-20 The Brigham And Women's Hospital, Inc. Lipoxin compounds with prolonged half-life
US5430049A (en) * 1993-12-08 1995-07-04 Gaut; Zane N. Treating hyperproliferative disorders
SE9601677D0 (sv) * 1996-05-02 1996-05-02 Scotia Lipidteknik Ab New use
US6831186B2 (en) * 2001-11-06 2004-12-14 Schering Aktiengesellschft Lipoxin A4 analogs
US8815950B2 (en) * 2003-08-29 2014-08-26 Janssen Biotech, Inc. Pharmaceutical compositions and method of using levodopa and carbidopa
US20050203184A1 (en) * 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
ZA200703992B (en) * 2004-11-09 2009-08-26 Alcon Inc 5, 6, 7-Trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses

Also Published As

Publication number Publication date
JP2010509240A (ja) 2010-03-25
CN101534806A (zh) 2009-09-16
WO2008058098A3 (en) 2008-08-07
WO2008058098A2 (en) 2008-05-15
MX2009004962A (es) 2009-05-21
ZA200902909B (en) 2010-07-28
EP2079459A2 (en) 2009-07-22
TW200829232A (en) 2008-07-16
US20080108695A1 (en) 2008-05-08
BRPI0718540A2 (pt) 2013-11-19
KR20090086573A (ko) 2009-08-13
AU2007316482A1 (en) 2008-05-15
US20090156667A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
CN102482249B (zh) 用于治疗皮肤病症或疾病状态的tofa类似物
JP3356455B2 (ja) ケトプロフェンリジン塩を含む局所用親水性医薬組成物
JP3006888B2 (ja) メトロニダゾールもしくはメトロニダゾールとクリンダマイシンとの相乗混合物を主成分とする薬剤
ES2569371T3 (es) Compuestos del ácido 7,14-dihidroxidocosahexaenoico
US20070041910A1 (en) Pharmaceutical spray compositions comprising a bioactive agent, at least one volatile silicone and a non-volatile oily phase
AU2005282468B2 (en) Improved GHB compositions
WO2008127459A1 (en) Pharmacological treatment of psoriasis
EP1686972B1 (en) Sprayable composition for the administration of vitamin d derivatives
EP2887928B1 (en) Retinoids and use thereof
AU2012304407A1 (en) Topical itraconazole formulations and uses thereof
US20090156667A1 (en) Method of treating asthma, allergic rhinitis, and skin disorders
JP2002534389A (ja) 女性性機能障害の治療のための方法および組成物
EP4520752A1 (en) Carebastine salt and use thereof
EP2708230B1 (en) Composition for external skin use for inflammatory diseases
US20150105349A1 (en) (R)-(-)-1,2-propanediol compositions and methods
US8034839B2 (en) Method of treating ocular allergy
HUT65945A (en) Nonateraenoic acid derivaties and process for producing them
JP7257091B2 (ja) 認知症の治療及び予防薬
CN110840878B (zh) 一种用于治疗银屑病的化合物及其制备方法
JP4031089B2 (ja) 光線過敏症群治療剤
WO2025199182A1 (en) Treatment with 4-hydroxybenzoic acid to augment coq10 production
WO2023230418A1 (en) Mutual prodrugs of cromoglicic acid
EP1650210A1 (en) Therapeutic agent for hyperpotassemia and bone disease
WO2011096941A1 (en) Method of treating ocular allergy
HU211590A9 (hu) Izoprenoidvázas foszfolipáz A2 gátló vegyületek és az ezeket tartalmazó gyógyászati készítmények Az átmeneti oltalom az 1., 2. és 8-11. igénypontokra vonatkozik.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20141106